Depression + Suicide Flashcards
Sleep changes in depression
1- Increased sleep latency and night awakenings, early morning awakening
2- Decreased SWS
3- increased total duration and REM density (esp 1st part night)
4- Decrease REM latency (<60 min instead of 90 min)
most antidepressants suppress REM sleep
antidepressants with lower risk sexual s/e
- Agomelatine, buproprion, mirtazapine, vilazodone, vortioxetine = lower risk
2nd gen antidepressant that are superior
Superior antidepressants (CANMAT 2023)
Every Moment Sparks Vitality And Clarity
- Escitalopram (level 1) - Mirtazapine (level 1) - Sertraline (level 1) - Venlafaxine (level 1) - Agomelatine (level 2) Citalopram (level 2)
1st line adjunctive meds for nonresponse or partial response to AD
2nd line
CANMAT 2016:
1st line:
- Aripiprazole
- Quetiapine
- Risperidone
2nd line:
-Brexpripazole
-Bupropion
-Lithium
-Mirtaz/mianserin
-Modafinil
-Olanzapine
-Triiodothyronine
Catatonia criteria
Need 3/12
6 Positive:
- Grimacing
- Mannerism (odd repetitive - ex saluting)
- Stereotypies (repetitive, not purposeful)
- Echolalia
- Echopraxia
- Psychomotor agitation
6 Negative
-Catalepsy (posture against gravity)
-Stupor (absence of motor activity)
-Waxy flexibility
-Negativism (opposition)
-Mutism (absence of response_
-Posturing (maintaining actively a posture)
MDD treatment recommendations
ie Rx vs therapy for mild/mod/severe
Recommendations:
- Mild w low dangerosity: psychotherapy or Rx have similar benefits. Psychotherapy preferred bc lower risk. Can consider natural products or digital health intervention
- Mod w low-mod dangerosity:
○ Can do either Rx or psychotherapy, or combo
○ Pharmacotherapy slightly better in acute phase for depressed mood, guilt, SI, anxiety, somatic Sx
○ Psychotherapy, specifically CBT more effective medium to long term (6-12 months)
○ Exercise, natural products, or guided DHI can be considered in monotherapy
- Severe w mod/severe dangerosity: ○ Combo Rx + psychotherapy ○ If psychotic symptoms, combine AD + APA
Psychotherapy treatment of depression (1st, 2nd, 3rd line)
1st line: CBT, IPT, behavioral activation
2nd line: MBCT, CBASP, problem-solving therapy, brief psychodynamic therapy, transdiagnostic psychological treatment of emotional problems
3rd line: ACT, long-term psychodynamic therapy (esp if comorbid PD), metacognitive therapy, motivational interviewing
Recommendations for MDE w mixed features
1st line AD
2nd line: lurasidone
Recommendations for MDE w cognitive dysfunction
1st line vortioxetine
2nd line bupropion, duloxetine, SSRI
Recommendations for MDE w sleep d/o
1st line agomelatine
2nd line: mirtazapine, quetiapine XR, trazodone
Recommendations for MDE w somatic symptoms
1st line: duloxetine (pain), bupropion (fatigue)
2nd line: duloxetine (fatigue), other SNRI (pain), SSRI (pain
-Recommendations MDE w sleep d/o:
1st line agomelatine, 2nd line mirtazapine, quetiapine XR, trazodone
Recommendations MDE + menopause
1st lien: desvenlafaxine, CBT
2nd line: transdermal estradiol > citalopram, duloxetine, escitalopram, mirtax, venlafaxine XR, quetiapine XR
>
see guidelines for rest
Recommendations MDE + EtOH
1st line: mirtaz, naltrexone, naltrexone + sertraline
2nd line: antabuse adjunct
3rd line: escitalopram, amitryptiline, desipramine, imipramine, epival, memantine
recommendations MDE + ADHD
1st line: bupropion, AD + long acting stimulant, AD + TCC
2nd line: desipramine, nortryptiline, venlafaxine
3rd line: AD + short acting stimulant, AD + atomoxetine, AD + lisdexamfetamine